App-Quantinova.ai

The Thromboembolism in Inflammatory Bowel Disease - apropos of 28 cases

A. Oliveir - European Crohn’s and Colitis Organisation (ECCO) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Validation of a risk score predicting post-surgical complications in patients with inflammatory bowel diseases

B. Gondal - European Crohn’s and Colitis Organisation (ECCO) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Hyperprolactinemia during antipsychotics treatment has a risk of venous thromboembolism

Masamichi Ishioka - International College of Neuropsychopharmacology (CINP) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Fibrinogen (IV)

Autoimmune Encephalitis in the ICU: Serological Spectrum, Clinical Courses, Complications and Outcomes

Manoj Mittal - American Academy of Neurology (AAN) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Rituximab

Emergency Room Neuro-ophthalmology

Janet C. Rucker - American Academy of Neurology (AAN) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Cerebral Venous Thrombosis after Autologous Stem Cell Transplantation

Hermina D Fernandes - European Group for Blood and Marrow Transplantation (EBMT) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

A Phase II, Safety and Efficacy Study of Fixed Dose Radioimmunotherapy (Zevalin, yttrium-90 ibritumomab tiuxetan) for Patients with Incomplete Response to Chemotherapy Prior to Autologous Stem Cell Transplant (ASCT) for Multiple Myeloma

Limin Gao - European Group for Blood and Marrow Transplantation (EBMT) , 2015

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Ibritumomab tiuxetan with yttrium-90

Management of Catheter-Related Thrombosis in Patients Undergoing Autologous Stem Cell Transplantation

Manish Sharma - European Group for Blood and Marrow Transplantation (EBMT) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

The Incidence of Venous Thromboembolism (VTE) in 892 Allogeneic Hematopoietic Cell Transplant (allo-HCT) Recipients ( A single institution study comparison of VTE incidence with sirolimus versus non-sirolimus-based GVHD prophylaxis)

John Mathews - European Group for Blood and Marrow Transplantation (EBMT) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

fludarabine tablet

Impact of Addition of Alcohol-Impregnated Port Protectors to Post Central Line Insertion Bundle in the Adult Blood and Marrow Transplant Population

Angela Nooner - European Group for Blood and Marrow Transplantation (EBMT) , 2015

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Venous thrombosis

N/A

Application to international guidelines in treatment of thromboembolic events in cancer patients: A hospital-based cohort study in Paris, France.

Isabelle Mahe - American Society of Clinical Oncology (ASCO) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Methadone hydrochloride

Novel algorithms to predict the occurrence of in-hospital venous thromboembolism in cancer patients: Machine learning classifiers developed from the 2012 national inpatient sample.

Spencer L. James - American Society of Clinical Oncology (ASCO) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Incidence of venous thromboembolism (VTE) and Khorana s score (KS) in ambulatory high-grade glioma (HGG) patients receiving chemotherapy.

Pedro Perez Segura - American Society of Clinical Oncology (ASCO) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Predictors of venous thromboembolism in patients with glioblastoma multiforme.

Shahzaib Nabi - American Society of Clinical Oncology (ASCO) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Bevacizumab

Venous thromboembolism in patients with glioblastoma: Risk factors and prognostic importance.

Natasha Catherine Edwin - American Society of Clinical Oncology (ASCO) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Hypoxia as a measure of functional status of glioblastoma vasculature

Amirhassan Alamsahebpou - Society for Neuro-Oncology (SNO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Venous thrombosis

Aflibercept

A retrospective analysis of intracranial hemorrhage in patients receiving anticoagulation for venous thromboembolism in the setting of glioblastoma

Michael N. Khour - Society for Neuro-Oncology (SNO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Association between level of tumor markers and development of venous thromboembolism in patients with pancreatic, colorectal and ovarian cancer: A retrospective case-control study.

Srijana Rai - American Society of Clinical Oncology (ASCO) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

A phase II clinical trial on combined axitinib and transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC): Final results and evaluation of clinical predictor for response.

Stephen Lam Chan - American Society of Clinical Oncology (ASCO) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Inlyta

Sorafenib plus intra-arterial cisplatin versus sorafenib alone in patients with advanced hepatocellular carcinoma: A randomized phase II trial.

Masafumi Ikeda - American Society of Clinical Oncology (ASCO) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Cisplatin

Filters

7277 Abstracts